Wyeth Low-Dose PremPro Osteoporosis sNDA Filing Planned For June

Wyeth-Ayerst will file a low-dose PremPro sNDA for osteoporosis by the end of June, North American President Joseph Mahady said during American Home Products' May 16 analyst meeting in New York City.

More from Archive

More from Pink Sheet